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The glucose-sensitive insulin-secretion (GSIS) phenotype is relatively unstable in long-term cul-
ture of beta cells. The purpose of this study was to investigate relative changes in the proteome
between glucose-responsive (low passage) and glucose non-responsive (high passage) murine
MIN-6 pancreatic beta cells. The 2D-DIGE and subsequent DeCyder analysis detected 3351 pro-
tein spots in the pH range of 4–7. Comparing MIN-6(H) to MIN-6(L) and using a threshold of
1.2-fold, the number of proteins with a decrease in expression level was 152 (4.5%), similar was
3140 (93.7%) and increased 59 (1.8%). From the differentially expressed proteins identified in
this study, groups of proteins associated with the endoplasmic reticulum (ER) and proteins
involved in oxidative stress were found to be significantly decreased in the high-passage (H pas-
sage) cells. These proteins included endoplasmic reticulum protein 29 (ERp29); 78-kDa glucose-
related protein, (GRP78); 94-kDa glucose-related protein (GRP94); protein disulphide isomerase;
carbonyl reductase 3; peroxidoxin 4 and superoxide dismutase 1. These results suggest that non-
GSIS MIN-6 cells do not have the same ability/capacity of glucose-responsive MIN-6 cells to
successfully fold, modify or secrete proteins and counteract the problems associated with oxida-
tive stress.
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1 Introduction
Diabetes mellitus is a disabling disease that currently affects
at least 170 million people worldwide and the incidence is
growing at an alarming rate [1, 2]. Cell replacement therapies
are potential alternatives to the insulin injections currently
employed to control blood glucose in diabetes, and it has
been demonstrated that this condition may be cured, at least
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on a temporary basis, by transplantation of pancreatic islets
isolated from donor pancreas [3]. However, the shortage of
human islet cells represents a limitation for large-scale use of
islet transplantation to cure patients with diabetes. Alter-
native sources of beta cells with a suitably stable phenotype
have yet to be defined [4]. A fundamental characteristic of
suitable replacement cells is their ability to secrete mature
insulin in response to physiological changes in blood levels
of glucose and other nutrients (glucose-sensitive insulin
secretion, GSIS). Unfortunately, studies of such cells by us
[5] and others have indicated that this necessary regulated
secretion is lost in beta cell lines such as MIN-6 with
passaging of these cells in culture. A better understanding of
the complex nature of GSIS is necessary to allow the pre-
vention or correction of such problems in the future.
Beta cells are specialized for the synthesis of high levels
of insulin; the correct folding of proinsulin in the ER is
essential for the efficient production of insulin. Molecular
chaperones are a specialized subset of proteins whose func-
tion is to assist other proteins in achieving proper folding in
the ER. Many chaperones are heat shock proteins, that is,
proteins expressed in response to elevated temperatures or
other cellular stresses, and include 78-kDa glucose-regulated
protein (GRP78), GRP58, GRP94, protein disulphide iso-
merase (PDI), calreticulin, 29-kDa ER protein (ERp29).
Altered expression levels of several proteins including
GRP78, GRP94 and PDI have been shown to be associated
with the pathophysiology of diabetes [6–11].
Oxidative stress, defined as a persistent imbalance be-
tween the production of highly reactive oxygen species (ROS)
and/or reactive nitrogen species (RNS) and antioxidant
defences is likely to be involved in progression of pancreatic
beta cell dysfunction. In healthy beta cells, a balance of gen-
erating and neutralizing ROS and RNS establishes the redox
homeostasis, which is important for normal cell function.
Examples of ROS include charged species such as super-
oxide and the hydroxyl radical and uncharged species such as
hydrogen peroxide. Beta cells are sensitive to ROS and RNS
because they are low in free-radical quenching (antioxidant)
enzymes such as catalase, glutathione peroxidase, and
superoxide dismutase and this has also been shown to be
greatly involved in the pathophysiology of diabetes [12, 13].
The aim of this study was to examine differential regula-
tion of the proteome associated with continuous culture of
MIN-6 cells and corresponding loss of GSIS phenotype to
enable future development of potential methods whereby
relevant beta cell functions could be preserved in long-term
culture [14–16].
2 Materials and methods
2.1 MIN-6 culture
MIN-6 cells (generously donated by Dr. Yamamoto, Kuma-
moto University school of Medicine, Japan) were grown in
DMEM containing 20% heat-inactivated FCS and were cul-
tured at 377C with 5% CO2. Routine sterility checks, includ-
ing screening for Mycoplasma, indicated that the cells were
clear of contamination. MIN-6 (H passage) at passage 40
cells was established by sub-culturing MIN-6 (L passage)
cells from passage 18, as previously described [5].
2.2 GSIS analysis of MIN-6 cells
MIN-6 cells were seeded at 26105 cells/well in a 24-well
plate, and were allowed to grow for 72 h prior to the GSIS
assay. Following this, 16KRB (Krebs-Ringer bicarbonate)
buffer was prepared from an aliquot of frozen 106stock
(36.525 g NaCl, 2.2 g KCl, 0.941g CaCl2 + 2H2O, 1.22 g
MgCl2 + 6H2O, 29.8g HEPES dissolved in 500 mL H2O).
BSA was added to a final concentration of 0.1%, and the
KRB-BSA was pH-adjusted to 7.36 at 197C with 1 mol/L
NaOH. This solution was incubated for 30 min at 377C and
5% CO2. Glucose concentrations of 0, 3.3, 10, 16.7, and
26.7 mmol/L were prepared in the conditioned 16KRB and
were subsequently placed at 377C and 5% CO2 for 30 min.
MIN-6 cells to be analyzed were rinsed (twice) in 16KRB
and were equilibrated at 3.3 mmol/L glucose for 30 min at
377C. After equilibration, the glucose-containing stimulation
media were added (1 mL/well), incubated at 377C and 5%
CO2 for 60 min. The GSIS assay was then terminated by
placing the plate on ice. Conditioned medium (500 mL) was
removed from each well, placed in an ice-cold Eppendorf
tube, centrifuged at 2500 rpm for 5 min and 200 mL of the
supernatant was removed for analysis by (pro)insulin ELISA
(Mercodia, 10-1124-10) following the manufacturer’s
instructions.
2.3 Immunofluorescence
MIN-6(L) and MIN-6(H) were plated on glass chamber slides
(NUNC) and cultured at 377C, 5% CO2 for 5 days before
analysis. Cells were washed in PHEM buffer (PIPES
60 mMol/L, HEPES 25 mMol/L, EGTA 10 mMol/L, MgCL2
2 mMol/L) and fixed in 4% paraformaldehyde, 0.5% gluter-
aldehyde in PHEM for 20 min at room temperature. Cells
were permeabilized with 0.1% Triton X-100 in PHEM. Free
aldehyde groups were reduced with 0.1% w/v sodium boro-
hydride in PBS. Cells were blocked for 30 min in 10% nor-
mal goat serum (NGS) in PHEM at room temperature fol-
lowed by overnight incubation with 10 mg/mL rat anti-insu-
lin (R&D Systems) in PHEM/0.1% NGS. Cells were
incubated with 8 mg/mL goat anti-rat IgG 488 Alexa Fluor
(Molecular Probes; A11006) in 0.1% NGS in PHEM for 1 h at
room temperature. Nuclei were counterstained by incubat-
ing slides at room temperature for 20 min with 1 mg/mL
RNase A (Sigma Aldrich) followed by staining for 5 min with
propidium iodide (Biotium). The slides were examined by
confocal laser scanning microscopy using a Leica TCS
AOBS.
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2.4 Sample preparation and protein labelling
Cells at approximately 80% confluence were washed twice in
PBS, twice in sucrose buffer before being lysed in buffer
containing (4% w/v CHAPS, 7 M Urea, 2 M thiourea,
10 mM Tris-HCl, 5 mM magnesium acetate pH 8.5), and
then homogenized by passing through a 25-gauge needle six
times. Insoluble material was removed by centrifugation at
14 000 rpm for 20 min at 107C. Protein concentration was
determined using the BSA protein assay kit (Bio-Rad).
Cell lysates were labelled with N-hydroxy succinimidyl
ester-derivatives of the cyanine dyes Cy2, Cy3, and Cy5 fol-
lowing the protocol described previously. Typically, 50 mg of
lysate was minimally labelled with 200 pmol of either Cy3 or
Cy5 for comparison on the same 2-D gel. Labelling reactions
were performed on ice in the dark for 30 min and then
quenched with a 50-fold molar excess of free lysine to dye for
10 min on ice. A pool containing equal amounts of all sam-
ples was also prepared and labelled with Cy2 to be used as a
standard on all gels to aid image matching and cross-gel sta-
tistical analysis. The Cy3 and Cy5 labelling reactions (50 mg of
each) from each lysate were mixed and run on the same gels
with an equal amount (50 mg) of Cy2-labeled standard [17].
2.5 Protein separation by 2-DE and gel imaging
Immobilized 24-cm linear pH gradient (IPG) strips, pH 4–7,
were rehydrated in rehydration buffer (7 M urea, 2 M thiou-
rea, 4% CHAPS, 0.5% IPG buffer, 50 mM DTT) overnight,
according to the manufacturers guidelines. IEF was per-
formed using an IPGphor apparatus (GE Healthcare) for
40 kV h at 207C with resistance set at 50 mA. Strips were
equilibrated for 20 min in 50 mM Tris-HCl, pH 8.8, 6 M
urea, 30% v/v glycerol, 1% w/v SDS containing 65 mM DTT
and then for 20 min in the same buffer containing 240 mM
iodoacetamide. Equilibrated IPG strips were transferred onto
18620-cm 12.5% uniform polyacrylamide gels poured be-
tween low fluorescence glass plates. Strips were overlaid with
0.5% w/v low melting point agarose in running buffer con-
taining bromophenol blue. Gels were run using the Ettan
Dalt 6 apparatus (GE Healthcare) at 2.5 W/gel for 30 min and
then 100 W total at 107C until the dye front had run off the
bottom of the gels. All the images were collected on a
Typhoon 9400 Variable Mode Imager (GE Healthcare). Sta-
tistics and quantitation of protein expression were carried
out in DeCyder software (GE Healthcare).
2.6 Spot digestion and MALDI-TOF analysis
Excision of protein spots, trypsin digestion, and protein
identification by MS analysis using an Ettan MALDI-TOF
Pro instrument from Amersham Biosciences was performed
according to an established methodology [18]. Preparative
gels containing 300 mg of protein were fixed in 30% v/v
methanol, 7.5% v/v acetic acid overnight and washed in
water, and total protein was detected by post-staining with
SyproRuby dye (Molecular Probes) for 3 h at room tempera-
ture. Excess dye was removed by washing twice in water, and
gels were imaged using a Typhoon 9400 Variable Mode Im-
ager (GE Healthcare) at the appropriate excitation and emis-
sion wavelengths for the stain. The subsequent gel image
was imported into the BVA module of DeCyder software and
was matched to images generated from DIGE analysis. Spots
of interest were selected and confirmed using this software
for subsequent picking using an Ettan Spot Picker. Gel plugs
were placed into a presilconized 1.5-mL plastic tube for
destaining, desalting and washing steps. The remaining
liquid above the gel plugs was removed and sufficient ACN
was added in order to cover the gel plugs. Following shrink-
age of the gel plugs, ACN was removed and the protein-con-
taining gel pieces were rehydrated for 5 min with a minimal
volume of 100 mM ammonium bicarbonate. An equal vol-
ume of ACN was added and after 15 min of incubation the
solution was removed from the gel plugs and the samples
were dried for 30 min using a vacuum centrifuge. Individual
gel pieces were then rehydrated in digestion buffer (12.5 ng
trypsin per ml of 10% ACN, 40 mM ammonium bicarbonate)
to cover the gel pieces. More digestion buffer was added if all
the initial volume had been absorbed by the gel pieces.
Exhaustive digestion was carried out overnight at 377C. After
digestion, the samples were centrifuged at 12 0006g for
10 min using a bench top centrifuge. The supernatant was
carefully removed from each sample and placed into clean
and silconized plastic tubes. Samples were stored at 2807C
until analysed by MS. For spectrometric analysis, mixtures of
tryptic peptides from individual samples were desalted using
Millipore C-18 Zip-Tips (Millipore) and eluted onto the sam-
ple plate with the matrix solution (5 mg/mL CHCA in 50%
ACN/0.1% TFA v/v). Mass spectra were recorded using the
MALDI TOF instrument operating in the positive reflector
mode at the following parameters: accelerating voltage
20 kV; and pulsed extraction: on (focus mass 2500). Internal
and external calibration was performed using trypsin auto-
lysis peaks at m/z 842.50, m/z 2211.104 and Pep4 mix,
respectively. The mass spectra were analysed using MALDI
evaluation software (GE Healthcare), and protein identifica-
tion was achieved with the PMF Pro-Found search engine.
2.7 Statistical analysis
Two-sided, Student’s t-tests were used to analyze differences
in protein levels between MIN-6(L) cell lysates and MIN-6(H)
cell lysates. A p-value of less than 0.01 was considered statis-
tically significant.
3 Results
3.1 Morphology of MIN-6 (L) and (H)
MIN-6(L) and MIN-6(H) cells were cultured at 377C, 5% CO2
for 5 days prior to analysis using phase contrast light mi-
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croscopy. This contrast-enhancing optical technique used to
produce high-contrast images of transparent specimens, was
performed at 106, 206and 406magnification by imagin-
ing the living, unfixed cells using a Nikon Optiphot micro-
scope with phase contrast rings. Phase contrast light mi-
croscopy indicates that MIN-6(L) cells that are glucose-
responsive tend to grow closely together, forming discrete
colonies (Fig. 1A), whereas MIN-6(H) cells, shown in
(Fig. 1B), which have lost their glucose-responsiveness with
culturing, appear to be more disperse, stretched cells.
3.2 Immunofluorescence
Laser scanning confocal microscopy (LSCM) analysis of
(Fig. 1C) MIN-6(L) and (Fig. 1D) MIN6-(H) cells indicates insu-
lin (green staining) to be located in cytoplasmic granules. The
numbers and localisation of insulin granules are apparently not
significantly different between these twocell populations.Nuclei
were stained with propidium iodide (red staining).
3.3 GSIS from MIN-6 H passage and L passage cells
As shown in Fig. 2, MIN-6 (L) cells secrete insulin in a glu-
cose-regulated manner, with an approximately 5.5-fold
increase in secreted product between 3.3 and 26.7 mM glu-
cose. In contrast to this, MIN6 (H) cells do not show a func-
tional GSIS response, i.e. the basal secretion of insulin from
these cells is not influenced by the glucose content of their
environment.
Figure 1. Phase contrast light microscopy indicates that MIN-6(L)
cells, which are glucose-responsive tend to grow closely togeth-
er, forming discrete colonies (A), whereas MIN-6(H) cells, shown
in (B), which have lost their glucose-responsiveness with cultur-
ing, appear to be more disperse, stretched cells. Scale bar 25 mm.
LSCM analysis of (C) MIN-6(L) and (D) MIN6-(H) cells indicates
insulin (green staining) to be located in cytoplasmic granules.
The numbers and localisation of insulin granules are apparently
not significantly different between these two cell populations.
Nuclei were stained with propidium iodide (red staining). Scale
bar 10 mm.
Figure 2. MIN-6(L) cells secrete (pro)insulin in a glucose-regu-
lated manner (hashed bars). This regulated secretion is no longer
apparent following long-term culture/passaging of MIN-6(H) cells
(black bars). Results represent means 6 SD from three experi-
ments.
3.4 Effects of continuous passaging of MIN-6 cells on
protein expression patterns using 2D-DIGE (IEF
pH range 4-7)
Fifty micrograms of protein from each sample was labelled
with Cy2, Cy3, or Cy5. Eight samples each from MIN-6(L)
and MIN-6(H) (experimental design included independent
biological samples/biological replicates) were labelled with
Cy3 and Cy5, respectively. All 16 samples employed in the
experiment were used in the Cy2-labelled internal pooled
standard. Samples were combined and separated by 2-DE.
For DeCyder image analysis, the differential in-gel analysis
mode of DeCyder was first used to merge the Cy2, Cy3, and
Cy5 images for each gel and to detect spot boundaries for the
calculation of normalized spot volumes/protein abundance.
At this stage, features resulting from non-protein sources,
namely dust particles and scratches were filtered out. The
analysis was used to rapidly calculate abundance differences
between samples run on the same gel. The biological varia-
tion analysis mode of DeCyder was then used to match all
pair wise image comparisons from difference in-gel analysis
for a comparative cross-gel statistical analysis. Operator
intervention was required at this point to set landmarks on
gels for more accurate cross-gel image superimposition.
Comparison of normalized Cy3 and Cy5 spot volumes with
the corresponding Cy2 standard spot volumes within each
gel gave a standardizedabundance. This value was compared
across all gels for eachmatched spot and a statistical analysis
was performed.
A total of 3351 protein spots were detected in the pH
range of 4–7. Comparing MIN-6(H) to MIN-6(L) and using a
threshold of 1.2-fold, the number of proteins with a decrease
in expression level was (4.5%), similar 3140 (93.7%) and
increased 59 (1.8%). From the data generated, it is clear that a
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significant number of proteins are differentially expressed
between MIN-6(H) cell lysates and MIN-6(L) cell lysates. The
migration patterns and exact location of the identified pro-
teins that were found to be differentially expressed are
shown (Fig. 3).
The 35 differentially expressed proteins passed certain
criteria for inclusion in the list, including appearing in all
gels, a p-value of less than 0.01 and for protein identification
an expectation value of 0.00 (Table 1). An expectation value of
zero denotes a perfect match; an expectation value of 0.01
indicates a 1% chance that the identification is random. All
reported identifications in this study have an expectation
value of 0.00. The 35 differentially expressed proteins identi-
fied were found to have a broad range of functions, including
chaperone activity, DNA binding, signal transduction, extra-
cellular structure, growth factors, cell motility and metabo-
lism/catabolism. From the data acquired, it is clear that the
majority of proteins identified in this study is involved in
chaperone activities and in metabolism/catabolism (Fig. 4).
Four differentially expressed proteins associated with the
ER and specifically involved in chaperone activity, namely
GRP94, GRP78, PDI and ERp29 were identified. The abun-
dance of all four proteins was found to be significantly
decreased in MIN-6(H) compared to MIN-6(L).
GRP94 (2.73-fold decrease) is a resident protein of the ER
and is induced by the accumulation of unfolded proteins. The
GRP78/BiP (2.91-fold decrease) belongs to the family of
~70-kDa heat shock proteins (HSP70) and is associated with
newly synthesised proteins. PDI involved in disulphide-bond
formation and isomerization, as well as the reduction of di-
sulphidebonds inproteinswas found tobe2.44decreased inH
passage compared to L passage cells. A recently characterized
protein, ERp29 (2.34-fold decrease) is closely related to these
chaperone proteins and appears to be up-regulated during ER
stress conditions. This soluble protein is localized to the lumen
of the ER in all mammalian cells (Table 1 and Fig. 5).
The majority of proteins identified was found to be
involved in metabolism/catabolism. Of these proteins car-
bonyl reductase 3, peroxidoxin 4 and superoxide dismutase
are known to have similar functions as antioxidant enzymes
and protecting cells from free radical-mediated damage.
Carbonyl reductase plays a unique role in the detoxification
of reactive aldehydes derived from lipid peroxidation and was
found to display a 3.54-fold decrease in H passage cells. Per-
oxiredoxin 4 (2.77-fold decrease) represents a member of a
recently discovered family of antioxidant proteins. Super-
oxide dismutase 1 (1.97-fold decrease) is a very well docu-
mented antioxidant that catalyses the conversion of super-
oxide radicals to molecular oxygen. Their function is to
destroy the radicals that are normally produced within cells
and are toxic to biological systems (Table 1 and Fig. 5).
Analysis of the protein expression using DeCyder soft-
ware provided 3-D simulation of the protein spots, allowing
an objective view for the comparison of spot intensity
Figure 3. The 2D-DIGE gels showing the fluorescent signal obtained from 150 mg of MIN-6 lysates and analyzed using minimal labelling.
The 2D-DIGE gel shows the separation of approximately 3500 proteins by molecular weight and pI. Displayed on the gel are the locations of
the 35 differentially expressed proteins identified in this study.
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Figure 4. Pie chart displaying the func-
tions of the 35 differentially expressed
proteins in MIN-6(H) cells versus MIN-
6(L) cells.
Table 1. Table showing identification, average ratio, t-test scores, theoretical molecular weight (Mw), theoretical pI, % coverage and
expectation values for each of the 35 differentially expressed proteins in MIN-6(H) cells versus MIN-6(L) cells
Spot
number
Name t-test Av.
ratio
Theoreti-
cal pI
Theoreti-
cal Mw
%
Coverage
Expecta-
tion value
1 3-Phosphoglycerate dehydrogenase 0,00087 2,65 6,1 57370 15,80% 0
2 6-Phosphogluconolactonase 0,00019 21,31 5,6 27460 26,80% 0
3 6-*Yruvoyl-tetrahydropterin synthase/dimerization cofactor 4,90E-07 21,75 6,28 12035 29% 0
4 Annexin A4 0,00032 1,99 5,4 36200 43,90% 0
5 Bisphosphate 3’-nucleotidase 1 0,0047 21,24 5,5 33520 44,50% 0
6 Carbonyl reductase 3 3,40E-07 23,56 6,2 31330 18,80% 0
7 Chaperonin subunit 2 (beta) 0,0051 1,22 6 57800 38,70% 0
8 Chromatin assembly factor 1 subunit C (CAF-1 subunit) 2,40E-08 1,85 4,95 52914 37,40% 0
9 Protein 1 homolog gamma (HP1 gamma) 1,10E-07 2,41 5,13 21013 29,50% 0
10 Chromogranin A precursor (CgA) 3,00E-07 2,47 4,65 18571 41,60% 0
11 Deoxyuridine triphosphatase 4,00E-07 1,41 5,7 17540 44,40% 0
12 Endoplasmic reticulum protein ERp29 precursor 8,90E-12 22,34 5,9 28862 30,50% 0
13 Enolase 1, alpha non-neuron 2,10E-05 21,53 6,4 47450 22,40% 0
14 Galactose-4-epimerase, UDP 0,00018 22,86 6,3 38550 19,50% 0
15 Heat shock 70-kDa protein 5 (glucose-regulated protein) 9,30E-07 22,91 5 72520 40,60% 0
16 High mobility group box 1 (Amphoterin) 8,20E-10 2,18 6,15 28573 24,70% 0
17 Hypoxanthine guanine phosphoribosyl transferase 6,60E-05 21,75 6,21 24756 30,60% 0
18 Malate dehydrogenase, cytoplasmic 5,50E-06 21,61 6,2 36630 20,10% 0
19 Peroxiredoxin 4 1,10E-13 22,77 6,67 31261 35,00% 0
20 Phosphoglycerate mutase 1 2,00E-06 2,95 6,7 28930 33,90% 0
21 Prohibitin 7,30E-05 1,31 5,6 29860 20,20% 0
22 Prolyl 4-hydrolase, beta polypeptide;protein disulfide isomerase 1,40E-07 22,44 4,8 57440 40,90% 0
23 Proteasome (prosome, macropain) subunit, alpha type 1 0,00018 21,29 6 29810 32,50% 0
24 Proteasome (prosome, macropain) 28 subunit 0,00015 21,33 5,5 28790 25,40% 0
25 Protein phosphatase 1, catalytic subunit, beta 0,0019 1,25 5,8 37970 33,50% 0
26 S-adenosylhomocysteine hydrolase 2,60E-06 1,45 6 48170 18,80% 0
27 Stathmin 1 3,50E-05 1,57 5,76 17205 47,70% 0
28 Stromal cell -derived growth factor 4,00E-10 22,28 6,3 18080 28,00% 0
29 Succinyl-CoA ligase [GDP-forming] beta chain 9,80E-05 22,59 5,8 44040 15,10% 0
30 Superoxide dismutase 1, soluble 2,50E-08 21,97 6 16100 44,00% 0
31 Transaldolase 1 0,0048 1,5 6,6 37540 31,80% 0
32 Tropomyosin alpha 3 chain 3,40E-06 1,53 4,7 32900 21,80% 0
33 Ubiquitin thiolesterase 1,70E-10 2,98 5,14 25164 37,40% 0
34 Ubiquinol-cytochrome-c-reductase complex core protein 1 2,80E-07 1,6 5,8 53440 26,90% 0
35 Glucose Regulated Protein 94 1,60E-06 22,73 4,7 92041 16,80% 0
between the two images and statistical information.
Statistical analysis and 3-D images were generated in
the BVA module of DeCyder software. Representative
3-D images and statistical information displayed gra-
phically for both ERp29 and peroxidoxin-4 are shown
(Fig. 6).
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Figure 5. Diagram showing the sub-
cellular location for ERp29 (endoplasmic
reticulum protein 29), GRP78 (glucose-
related protein 78), GRP94 (glucose-
related protein 94), PDI, CBR3 (carbonyl
reductase 3), PRDX4 (peroxidoxin 4),
SOD1 (superoxide dismutase 1) and
how decreased expression levels may
contribute to a loss of GSIS (Glucose-
Sensitive Insulin Secretion) in glucose
non-responsive H passage MIN-6 beta
cells.
Figure 6. Statistical analysis and 3-D images for peroxidoxin-4 and endoplasmic reticulum protein
(ERp29). Statistical analysis and 3-D images were generated in the BVA module of DeCyder software.
4 Discussion
As a possible alternative to – and improvement on – the
existing therapies available for insulin-dependent dia-
betes, cultured beta cells offer enormous potential. How-
ever, for such cells to be considered an appropriate source
of transplantable tissue, it is of fundamental importance
that their secretion of insulin occurs in a regulated man-
ner, in response to physiological changes in blood glucose
levels.
The possibility of using isolated cultured beta cells in the
treatment of diabetes has prompted this current study of
differential protein expression between glucose-responsive
and glucose non-responsive MIN-6 cells. A detailed under-
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standing, through proteomic analysis, of the complex pro-
cesses involved in the loss of GSIS, found with passaging/
extended time in culture, may allow a greater insight into the
mechanisms involved. The main techniques used in this
study were 2D-DIGE and subsequent MS. The use of bio-
logical replicates from separately cultured cells allowed the
application of stringent statistical analysis to generate a list of
proteins displaying differential expression between H pas-
sage (glucose non-responsive; MIN-6(H)) and L passage
(glucose responsive; MIN-6(L)) MIN-6 cells.
In our previous study of MIN-6 cells at passages 17 to 22,
we established that MIN-6 is reproducibly glucose-respon-
sive, secreting insulin in response to increased glucose
levels. Following sub-culturing and continuous analysis of
glucose-responsiveness at increasing passage numbers, we
established that this response is completely lost by passage
40. Biological replicates selected for analysis in this study
were, therefore, p18 (MIN-6(L); L passage; glucose-respon-
sive) and p40 (MIN-6(H); high passage; glucose non-respon-
sive) cells [5].
Contradictory results in recent times have been reported
on the GSIS response of the murine beta-like cell line, MIN-
6. Some studies have reported the maintenance of GSIS
while others have documented the loss of this response with
increasing passage numbers and time in culture [5, 14, 19–
21]. Here, we report that L passage (passage 18) MIN-6 cells
respond to changes in glucose concentration, producing an
approximately 5.5-fold GSIS in response to 26.7 mmol/L,
compared to 3.3 mmol/L, glucose. After continuous culture
to passage 40, this GSIS was no longer present. Beta cells
play a central role in glucose homeostasis; therefore, beta cell
loss or dysfunction leads to the development of diabetes.
Using LSCM analysis we observed that the presence of
granules in similar numbers in the GSIS of both H and L
passage MIN-6 cells suggests that the observed change in
GSIS is not related to a deficiency in insulin capability. Phase
contrast light microscopy indicates that MIN-6(L) cells that
are glucose-responsive tend to grow closely together and
form discrete colonies whereas MIN-6(H) cells, which have
lost their glucose-responsivenesswith culturing, appear to be
more dispersed, stretched cells.
One of the characteristic features of beta cells is a highly
developed ER, which is essential for proper insulin folding,
packaging and secretion [22].The ER is one of the most
important organelles, serving several important functions,
including PTM, folding and assembly of newly synthesized
secretory proteins (hormones, antibodies, pancreatic
enzymes, etc.), and as a cellular calcium store. For proper
functioning, a protein folds in a characteristic 3-D structure
and may form a multimeric protein complex. The ER pro-
vides an environment perfectly suited for the folding and
assembly of proteins. Efficient and rapid protein folding is
assisted by molecular chaperones, folding factors and folding
sensors. Molecular chaperones are proteins and protein
complexes that bind to misfolded or unfolded polypeptide
chains and affect the subsequent folding processes of these
chains. Chaperones are found in all types of cells and cellular
compartments, and have a wide range of binding specifi-
cities and functional roles.
One of the most significant findings of the study reported
here was the differential expression of major proteins asso-
ciated with the ER, namely ERp29-, GRP78, GRP94- and
PDI, all of which have very similar or complementary func-
tions at the ER, especially in protein folding, disulphide bond
formation, PTM and protein secretion.
ERp29, characterised initially in 1997 [23], is a major
resident of the ER that seemingly plays an important role in
most animal cells [24, 25]. The expression of ERp29 reaches
its highest levels in secretory cells; seems to play an impor-
tant role in protein folding; consists of two domains of which
the N-terminal domain of ERp29 resembles the thioredoxin
module of PDI [26]; and has been shown to associate with
GRP78 and GRP94 [27]. Recently, Morand et al. [11] profiled
hepatic ER-associated proteins from control and fructose-fed
(insulin-resistant) hamsters using 2-DE and MS and found
ERp29 to be 4.5-fold down-regulated in fructose-fed hamster
livers. In our study, we found ERp29 to be significantly
decreased in MIN-6(H) cells compared to MIN-6(L) cells that
maintain their GSIS.
Protein profiling of human pancreatic islets by 2-DE
and MS found 23% of the proteins identified to be molec-
ular chaperones, including GRP78 and GRP94 [28]. GRP78
is an abundant ER protein and was originally identified as
a retention factor for unassembled IgG heavy chains in the
ER [29, 30]. Cycles of ATP binding and hydrolysis regulate
substrate binding and release from GRP78 [31], which is
now recognized as a key chaperone with multiple roles in
ER quality control, for example the translocation and fold-
ing of proteins [32, 33]. The abundant soluble ER-resident
GRP94 [34, 35], also provides chaperone and folding facil-
itation in the ER. Both GRP78 and GRP94 have previously
been implicated in the pathophysiology of diabetes. Wang
et al. [36] observed that BiP (GRP78) formed complexes
with wild-type proinsulin expressed in CHO cells. This
suggests that this association may occur physiologically in
pancreatic beta cells; however, this warrants further inves-
tigation. Expression of GRP78 and GRP94 is induced by
the presence of unfolded or unassembled protein subunits
within the ER [37–39]. A 2.73- and a 2.91-fold decrease in
GRP78 and GRP94, respectively, in the glucose non-
responsive MIN-6(H) cells suggests that the ER of this
phenotype does not intrinsically contain the same protein
folding/handling/secretory power as in the unaffected glu-
cose responsive MIN-6(L) passage phenotype. Many groups
have published data linking the roles of GRP78 and
GRP94 with the pathogenesis of diabetes [6, 8]. Our data
points to a “winding down” of a fully operational ER and
hence may partially explain the loss of GSIS associated
with continual culture of MIN-6 cells. Beta cells are ex-
tremely specialised cells adapted for glucose sensing and
insulin secretion, thus any disruption to this highly spe-
cific process will compromise its position in maintaining
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homeostasis. Together with ERp29, GRP78 and GRP94,
PDI is an intrinsic member of the ER with numerous
dedicated functions and characteristics.
The correct arrangement of disulphide bonds is impor-
tant for the proper stability and function of many proteins.
PDI is the enzyme responsible for catalyzing efficient for-
mation of native disulphide pairings in eukaryotic cells. PDI
is an ER-resident protein that catalyzes the oxidation of
dithiols and the reduction and isomerization of disulphide
bonds in secretory proteins. Of importance to diabetes is that
PDI is now regarded as an insulin-regulated gene [40, 41].
The loss of GSIS associated with H passage MIN-6 beta cells
coincides with a significant decrease in the abundance levels
of PDI. DIGE analysis of cell lysates from MIN-6 glucose
responsive and glucose non-responsive beta cells reveals a
2.44-fold decrease in PDI in the glucose non-responsive
phenotype.
Several models of diabetes have displayed a link to the ER
proteins identified in this study, namely ERp29, GRP78,
GRP94 and PDI. All these proteins have very similar or
complementary functions at the ER, especially with respect
to protein folding, bond formation, PTM and protein secre-
tion. From the data presented here, continuous culture of
MIN-6 cells results in the appearance of phenotypic changes.
Most notably, deviation from characteristic MIN-6 morphol-
ogy, growth patterns, loss of GSIS and a significant reduction
in the expression levels in ERp29, GRP78, GRP94 and PDI.
Therefore, it seems that the inability of the glucose non-
responsive phenotype to secrete insulin in response to ap-
propriate stimuli is intrinsically linked with the differential
regulation of the ER proteins in question.
Oxidative stress, defined as a persistent imbalance be-
tween the production of highly reactive molecular species
(chiefly oxygen and nitrogen) and antioxidant defences is
likely involved in progression of pancreatic beta cell dys-
function and is possibly caused by low levels of antioxidant
enzyme expressions, therefore making pancreatic beta cells
more vulnerable. Oxidative stress results from increased
content of ROS and/or RNS. Superoxide anions and the hy-
droxyl radical are examples of charged ROS, with hydrogen
peroxide (H2O2) being an example of an uncharged species
[42]. Maechler et al. [13] showed that oxygen stress generated
by short exposure of beta cell preparations to H2O2 increases
production of p21 and decreases insulin mRNA, cytosolic
ATP, and calcium flux in cytosol and mitochondria, and
causes apoptosis. They showed as well that the mitochondria
is a primary targets for hydrogen peroxide (H2O2) damage,
which will eventually interrupt the transduction of signals
normally coupling glucose metabolism to insulin secretion.
Beta cells are sensitive to ROS and RNS because they are
low in free radical quenching (antioxidant) enzymes such as
catalase, glutathione peroxidase, and superoxide dismutase
[43]. In this study, we found that the expression levels of car-
bonyl reductase 3, superoxide dismutase 1 and peroxiredoxin
4 to be significantly decreased in MIN-6(H) compared to
MIN-6(L) cells, which was associated with the loss of GSIS.
The decrease in abundance levels of these already low
expressed antioxidant enzymes suggests that the H passage
MIN-6 cells have little ability to counteract the damaging
affect of free radicals and that this may have an impact on
insulin secretion. Tiedge et al. [12] showed that the effects of
stable overexpression of glutathione peroxidase (Gpx), cata-
lase (Cat), or Cu/Znsuperoxide dismutase (SOD) can protect
insulin-producing RINm5F cells against oxidative damage.
In addition, the adenovirus-mediated catalase gene transfer
was also shown to reduce oxidant stress in human, porcine
and rat pancreatic islets [44].
From the data presented here, it is clear that loss of GSIS
is associated with a reduction in expression levels of free-
radical quenching (antioxidant) enzymes such as carbonyl
reductase 3, superoxide dismutase 1 and peroxiredoxin 4.
Recently, it was shown that chronic high glucose culture
caused impairment in glucose-sensitive insulin secretion in
DBA/2 islets, which have a genetic predisposition to failure,
and this may be the result of oxidative stress [45].
To conclude, we have identified 35 proteins differentially
expressed between glucose-responsive and glucose non-
responsive MIN-6 beta cells. Proteins associated with ER
functioning and oxidative stress were found to be particularly
affected. The results shown in this study suggest that shorter
culture times and a greater understanding of the protein
expression changes associated with the loss of GSIS in H
passage MIN-6 beta cells will contribute to the ultimate goal
of developing cell-based transplantation therapy for insulin-
dependent diabetes.
This work was supported by the PRTLI Cycle 3 Programme of
the Irish Higher Education Authority.
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